BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17156592)

  • 21. Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients.
    Alfieri AB; Cubeddu LX
    Br J Cancer; 1995 Mar; 71(3):629-32. PubMed ID: 7533519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Substance P and anticancer drug-induced emesis].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Tajiri T
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):903-6. PubMed ID: 17565253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary serotonin metabolite excretion during cisplatin chemotherapy.
    Wilder-Smith OH; Borgeat A; Chappuis P; Fathi M; Forni M
    Cancer; 1993 Oct; 72(7):2239-41. PubMed ID: 7690681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Hydroxyindoleacetic acid (5-HIAA) and cortisol excretion as predictors of chemotherapy-induced emesis.
    du Bois A; Vach W; Wechsel U; Holy R; Schaefer W
    Br J Cancer; 1996 Oct; 74(7):1137-40. PubMed ID: 8855988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs.
    Cubeddu LX; Hoffmann IS; Fuenmayor NT; Malave JJ
    Br J Cancer; 1992 Jul; 66(1):198-203. PubMed ID: 1379060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
    Cheirsilpa A; Sinthusake T; Songsakkaesorn A; Visawaprasit S; Chulaka K; Changkuingdee N
    Jpn J Clin Oncol; 2005 Dec; 35(12):695-9. PubMed ID: 16319109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
    J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial.
    Lajolo PP; de Camargo B; del Giglio A
    Am J Clin Oncol; 2009 Feb; 32(1):23-6. PubMed ID: 19194119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
    Yonemura M; Katsumata N; Hashimoto H; Satake S; Kaneko M; Kobayashi Y; Takashima A; Kato Y; Takeuchi M; Fujiwara Y; Yamamoto H; Hojo T
    Jpn J Clin Oncol; 2009 Jul; 39(7):443-8. PubMed ID: 19395466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin-related hiccups: male predominance, induction by dexamethasone, and protection against nausea and vomiting.
    Liaw CC; Wang CH; Chang HK; Wang HM; Huang JS; Lin YC; Chen JS
    J Pain Symptom Manage; 2005 Oct; 30(4):359-66. PubMed ID: 16256900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed.
    Erazo Valle A; Wisniewski T; Figueroa Vadillo JI; Burke TA; Martinez Corona R
    Curr Med Res Opin; 2006 Dec; 22(12):2403-10. PubMed ID: 17257454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between parameters of serotonin metabolism and emetogenic potential of platinum-based chemotherapy regimens.
    du Bois A; Vach W; Siebert C; Holy R; Ledergerber M; Wechsel U; Kriesinger-Schroeder H
    Support Care Cancer; 1997 May; 5(3):212-8. PubMed ID: 9176967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Herrington JD; Jaskiewicz AD; Song J
    Cancer; 2008 May; 112(9):2080-7. PubMed ID: 18327813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.
    Booth CM; Clemons M; Dranitsaris G; Joy A; Young S; Callaghan W; Trudeau M; Petrella T
    J Support Oncol; 2007 Sep; 5(8):374-80. PubMed ID: 17944146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tropisetron: optimal dosage for children in prevention of chemotherapy-induced vomiting.
    Cappelli C; Ragni G; De Pasquale MD; Gonfiantini M; Russo D; Clerico A
    Pediatr Blood Cancer; 2005 Jul; 45(1):48-53. PubMed ID: 15768378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
    Abali H; Celik I
    Cancer Invest; 2007; 25(3):135-9. PubMed ID: 17530482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
    Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.